CompletedNCT04680910
Propofol and brain slow waves in treatment-resistant depression
About this title
Read the official source — NCT04680910Medication studyAges 60+United States
Understand this study
Who was this study for?
Listed age limits: from 60 years.
- Listed locations
- St LouisSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateStarted: January 14, 2021
- Recruitment status
- Completed
- Enrollment listed in the registry
- 16
- Sponsor
- Washington University School of Medicine
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Diagnostic test, Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- Over 60 Years
- Official registry ID
- NCT04680910
- Official title
Show the full official title
Precision Targeting of Propofol-induced Electroencephalographic Slow Waves: a Novel Phase I Paradigm for Treatment-resistant Major Depressive Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
St Louis
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Washington University School of Medicine, a university.
Did this study involve medication?
Yes. The study involved medication, including Propofol.
Who was this study for?
Listed age limits: from 60 years.
